(COFB) Cofinimmo - Ratings and Ratios
Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003593044
COFB: Rental Properties, Healthcare Facilities, Offices, Nursing Homes
Cofinimmo SA, a seasoned player in the European real estate sector, has been navigating the market for four decades, specializing in the acquisition, development, and management of rental properties. Their diverse portfolio, valued at approximately €6.2 billion, is strategically spread across nine European countries, including Belgium, France, and Germany, positioning them as a significant player in the region.
The companys mission revolves around providing high-quality spaces for care, living, and work, directly enhancing the well-being of their occupants. This focus is evident in their substantial healthcare real estate portfolio, worth about €4.6 billion, a sector that offers stability and growth due to consistent demand for healthcare services.
As an independent entity, Cofinimmo adheres to stringent corporate governance standards and sustainability practices, which are crucial for investor confidence. Their operational efficiency is supported by a team of around 155 professionals across key European cities, ensuring effective portfolio management and tenant services.
Cofinimmos listing on Euronext Brussels and its REIT status in Belgium, France, and the Netherlands underscore its commitment to attracting investors through favorable tax structures. The oversight by the Financial Services and Markets Authority (FSMA) adds a layer of regulatory compliance, further bolstering investor trust.
From a financial standpoint, Cofinimmo boasts a market capitalization of around €2.08 billion. The forward P/E ratio of 8.90 indicates expectations for future earnings growth, while the P/B ratio of 0.60 suggests undervaluation relative to book value. The P/S ratio of 5.29 highlights a premium pricing, reflecting the quality and stability of their portfolio.
In summary, Cofinimmo SA presents an attractive investment opportunity with a strong focus on healthcare real estate, robust governance, and a strategic European presence, supported by favorable financial metrics.
Additional Sources for COFB Stock
COFB Stock Overview
Market Cap in USD | 2,492m |
Sector | Real Estate |
Industry | REIT - Healthcare Facilities |
GiC Sub-Industry | Diversified REITs |
IPO / Inception |
COFB Stock Ratings
Growth 5y | -45.7% |
Fundamental | - |
Dividend | 82.4% |
Rel. Strength | -5.23 |
Analysts | - |
Fair Price Momentum | 67.13 EUR |
Fair Price DCF | - |
COFB Dividends
Dividend Yield 12m | 20.95% |
Yield on Cost 5y | 14.69% |
Annual Growth 5y | 2.06% |
Payout Consistency | 93.7% |
COFB Growth Ratios
Growth Correlation 3m | 87.6% |
Growth Correlation 12m | -26.4% |
Growth Correlation 5y | -81.7% |
CAGR 5y | -6.69% |
CAGR/Max DD 5y | -0.12 |
Sharpe Ratio 12m | 0.25 |
Alpha | -4.22 |
Beta | 0.859 |
Volatility | 19.81% |
Current Volume | 103.3k |
Average Volume 20d | 80.8k |
As of April 03, 2025, the stock is trading at EUR 59.30 with a total of 103,319 shares traded.
Over the past week, the price has changed by -2.95%, over one month by +1.54%, over three months by +5.14% and over the past year by +7.43%.
Probably not. Based on ValueRay Analyses, Cofinimmo (BR:COFB) is currently (April 2025) not a good stock to buy. It has a ValueRay Growth Rating of -45.74 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COFB as of April 2025 is 67.13. This means that COFB is currently undervalued and has a potential upside of +13.2% (Margin of Safety).
Cofinimmo has no consensus analysts rating.
According to ValueRays Forecast Model, COFB Cofinimmo will be worth about 72.5 in April 2026. The stock is currently trading at 59.30. This means that the stock has a potential upside of +22.26%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 65.2 | 9.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 72.5 | 22.3% |